AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 173 filers reported holding AMAG PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 2.12 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $57,000 | -45.7% | 7,412 | -56.2% | 0.00% | 0.0% |
| Q1 2020 | $105,000 | -95.6% | 16,936 | -91.4% | 0.00% | -95.2% |
| Q4 2019 | $2,393,000 | -29.9% | 196,672 | -33.5% | 0.02% | -34.4% |
| Q3 2019 | $3,416,000 | -38.9% | 295,798 | -47.1% | 0.03% | -36.0% |
| Q2 2019 | $5,587,000 | -39.3% | 559,307 | -21.7% | 0.05% | -35.9% |
| Q1 2019 | $9,202,000 | -9.2% | 714,457 | +7.1% | 0.08% | -14.3% |
| Q4 2018 | $10,130,000 | +497.6% | 666,904 | +686.7% | 0.09% | +658.3% |
| Q3 2018 | $1,695,000 | +9870.6% | 84,769 | +9543.8% | 0.01% | – |
| Q2 2018 | $17,000 | +41.7% | 879 | +43.4% | 0.00% | – |
| Q1 2018 | $12,000 | +9.1% | 613 | -28.6% | 0.00% | – |
| Q4 2017 | $11,000 | 0.0% | 859 | +49.4% | 0.00% | – |
| Q3 2017 | $11,000 | -98.6% | 575 | -97.1% | 0.00% | -100.0% |
| Q3 2015 | $791,000 | – | 19,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 2,650,000 | $48,893,000 | 3.10% |
| Voce Capital Management LLC | 110,789 | $2,044,000 | 2.72% |
| Palo Alto Investors LP | 3,441,233 | $63,491,000 | 2.67% |
| FALCON POINT CAPITAL, LLC | 839,477 | $13,180,000 | 1.91% |
| EII CAPITAL MANAGEMENT, INC. | 119,690 | $2,208,000 | 0.83% |
| CLARK ESTATES INC/NY | 163,300 | $3,013,000 | 0.50% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 38,358 | $708,000 | 0.50% |
| Jabre Capital Partners S.A. | 120,000 | $2,214,000 | 0.43% |
| Credit Capital Investments LLC | 15,000 | $277,000 | 0.31% |
| Alambic Investment Management, L.P. | 151,442 | $2,794,000 | 0.30% |